GlobeNewswire Inc | Nov 10, 2020 04:01PM EST

November 10, 2020

LAKE FOREST, Ill., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc.(Assertio or the Company) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, announced that President, chief executive officer and director,Todd Smith will present at and participate in investor meetings at theStifel2020Virtual HealthcareConference onNovember 17, 2020. The presentation will take placeat11:20 am ET

A live audio webcast of the presentation can be accessed through the Investors section of the Company's website atwww.assertiotx.com. A replay of the webcast will be available on the Company's website following the live presentation.

About Assertio

Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital and pain and inflammation. Assertio has grown through business development including licensing, mergers and acquisitions. The Company seeks to leverage its commercial excellence to be the partner of choice. To learn more about Assertio, visit www.assertiotx.com.

Investor ContactLee RothBurns McClellan for Assertio Holdings, Inc.lroth@burnsmc.comir@assertiotx.com